National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, College of Life Sciences, Shaanxi Normal University, 710119, Xi'an, Shaanxi, China.
Commun Biol. 2023 Jun 8;6(1):618. doi: 10.1038/s42003-023-04993-x.
Mitochondria are dynamic organelles that are important for cell growth and proliferation. Dysregulated mitochondrial dynamics are highly associated with the initiation and progression of various cancers, including ovarian cancer. However, the regulatory mechanism underlying mitochondrial dynamics is still not fully understood. Previously, our study showed that carnitine palmitoyltransferase 1A (CPT1A) is highly expressed in ovarian cancer cells and promotes the development of ovarian cancer. Here, we find that CPT1A regulates mitochondrial dynamics and promotes mitochondrial fission in ovarian cancer cells. Our study futher shows that CPT1A regulates mitochondrial fission and function through mitochondrial fission factor (MFF) to promote the growth and proliferation of ovarian cancer cells. Mechanistically, we show that CPT1A promotes succinylation of MFF at lysine 302 (K302), which protects against Parkin-mediated ubiquitin-proteasomal degradation of MFF. Finally, the study shows that MFF is highly expressed in ovarian cancer cells and that high MFF expression is associated with poor prognosis in patients with ovarian cancer. MFF inhibition significantly inhibits the progression of ovarian cancer in vivo. Overall, CPT1A regulates mitochondrial dynamics through MFF succinylation to promote the development of ovarian cancer. Moreover, our findings suggest that MFF is a potential therapeutic target for ovarian cancer.
线粒体是细胞生长和增殖的重要细胞器,具有动态特征。线粒体动态失调与多种癌症(包括卵巢癌)的发生和发展密切相关。然而,线粒体动态的调控机制尚不完全清楚。先前的研究表明,肉毒碱棕榈酰基转移酶 1A(CPT1A)在卵巢癌细胞中高表达,促进卵巢癌的发展。本研究发现,CPT1A 通过调节线粒体分裂因子(MFF)促进线粒体分裂,从而促进卵巢癌细胞的生长和增殖。本研究进一步表明,CPT1A 通过线粒体分裂因子(MFF)调节线粒体分裂和功能,促进卵巢癌细胞的生长和增殖。机制上,我们发现 CPT1A 促进 MFF 在赖氨酸 302(K302)上的琥珀酰化,从而防止 Parkin 介导的 MFF 泛素蛋白酶体降解。最后,该研究表明 MFF 在卵巢癌细胞中高表达,且高 MFF 表达与卵巢癌患者的不良预后相关。MFF 抑制显著抑制卵巢癌在体内的进展。总之,CPT1A 通过 MFF 琥珀酰化调节线粒体动态,促进卵巢癌的发展。此外,我们的研究结果表明,MFF 可能是卵巢癌的潜在治疗靶点。